A 50-year-old female patient with diffuse PTL. by Yu Xia (8822)

Transient ATX overexpression decreases vessel branching but does not delay retinal vascularization. by Hiroshi Yukiura (741223)

rRL-KD treatment decreased inflammation after MSU-induced acute gout arthritis. by Fábio Mambelli (10005409)

The prevalence of undernourished children under five by household wealth status, educational status of mothers, place of residence, and regions in Ethiopia (DHS 2005 to 2016). by Frehiwot Birhanu (17507395)

Subjects:

Nucleotide sequence alignment of aflatoxin genes <i>Nor, Omt</i>, <i>Ver</i> and <i>aflR</i> treated with <i>U. epigea</i> extract, Ag/ZnO (Biosynthesized and Conventional) nanopar... by Martha Cebile Jobe (21175426)

Delayed boosting with ALVAC-HIV/AIDSVAX B/E or AIDSVAX B/E increases V1V2-specific IgG concentration and breadth. by LaTonya D. Williams (3140490)

Discovery of 2‑Ethoxy-5-isobutyramido‑<i>N</i>‑1-substituted Benzamide Derivatives as Selective Kv2.1 Inhibitors with In Vivo Neuroprotective Effects by Jie Zhou (28945)

“…In this work, a series of novel benzamide derivatives were designed and synthesized as Kv2.1 inhibitors, and extensive structure–activity relationships led to highly potent and selective Kv2.1 inhibitors having IC₅₀ values of 10^–8 M. …”

Discovery of 2‑Ethoxy-5-isobutyramido‑<i>N</i>‑1-substituted Benzamide Derivatives as Selective Kv2.1 Inhibitors with In Vivo Neuroprotective Effects by Jie Zhou (28945)

“…In this work, a series of novel benzamide derivatives were designed and synthesized as Kv2.1 inhibitors, and extensive structure–activity relationships led to highly potent and selective Kv2.1 inhibitors having IC₅₀ values of 10^–8 M. …”

Discovery of 2‑Ethoxy-5-isobutyramido‑<i>N</i>‑1-substituted Benzamide Derivatives as Selective Kv2.1 Inhibitors with In Vivo Neuroprotective Effects by Jie Zhou (28945)

“…In this work, a series of novel benzamide derivatives were designed and synthesized as Kv2.1 inhibitors, and extensive structure–activity relationships led to highly potent and selective Kv2.1 inhibitors having IC₅₀ values of 10^–8 M. …”

Magnitude-breadth of linear V2 hotspot binding response. by LaTonya D. Williams (3140490)

Placental gene expression at E9.5 and E11.5. by Hui Zhao (7395)

Loss of Prox1a decreases PR production at 120 hours post-ablation. by Kellie Veen (17343374)

The saturated fatty acid palmitate decreases viability and induces apoptosis in HUVECs. by Dustin M. Lee (8207457)

DHA decreased cell viability in HepG3 cells. by Arlet Hernandez (12289155)

Scatterplot of fold-change expression for B-cell-specific mRNA transcripts in the whole blood. by Luísa Camacho (5508251)

“…The horizontal gray bars indicate a 2-fold increase and decrease in expression compared to control. …”

Zeb1 overexpression leads to extramedullary hematopoiesis/splenomegaly, enhanced myeloid cell development, and monocyte lineage skewing. by Jueqiong Wang (11467505)

IC₅₀s data of antimalarials against controls. by Winnie Okore (14139712)

Fibrosis markers. by Dwight D. Harris (14484648)

Immunoblotting for TGF-beta, alpha-actinin, MMP-13, and mTOR. by Dwight D. Harris (14484648)

Immunoblotting for JAK, STAT, and SMAD. by Dwight D. Harris (14484648)